Sero-diagnosis of mycobacterium avium complex lung disease using serum immunoglobulin a antibody against glycopeptidolipid antigen in Taiwan

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Shu, Chin Chung ^a,b   Ato, Manabu ^c   Wang, Jann Tay ^b   Jou, Ruwen ^d   Wang, Jann Yuan ^b   Kobayashi, Kazuo ^e   Lai, Hsin Chih ^f   Yu, Chong Jen ^b   Lee, Li Na ^b   Luh, Kwen Tay ^b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c National Institute of Infectious Diseases   (Japan)

^d CENTER FOR DISEASE CONTROL   (Taiwan)

^e Asoka Hospital   (Japan)

^f CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; FEMALE; GLYCOCONJUGATES; HUMANS; IMMUNOGLOBULIN A; MALE; MIDDLE AGED; MYCOBACTERIUM AVIUM COMPLEX; MYCOBACTERIUM AVIUM-INTRACELLULARE INFECTION; PNEUMONIA, BACTERIAL; PROSPECTIVE STUDIES; RISK FACTORS; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 84894122544     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0080473     Document Type: Article

References (19)

1. Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C et al. (2007) An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 175: 367-416. doi:10.1164/rccm.200604-571ST. PubMed: 17277290.
2. Lai CC, Tan CK, Chou CH, Hsu HL, Liao CH et al. (2010) Increasing incidence of nontuberculous mycobacteria, Taiwan, 2000-2008. Emerg Infect Dis 16: 294-296. doi:10.3201/eid1602.090675. PubMed: 20113563.
3. Shu CC, Lee CH, Hsu CL, Wang JT, Wang JY et al. (2011) Clinical characteristics and prognosis of nontuberculous mycobacterial lung disease with different radiographic patterns. Lung 189: 467-474. doi:10.1007/s00408-011-9321- 4. PubMed: 21956280.
4. Field SK, Cowie RL (2006) Lung disease due to the more common nontuberculous mycobacteria. Chest 129: 1653-1672. doi:10.1378/chest.129.6.1653. PubMed: 16778288. (Pubitemid 43894999)
5. Koh WJ, Kwon OJ, Jeon K, Kim TS, Lee KS et al. (2006) Clinical significance of nontuberculous mycobacteria isolated from respiratory specimens in Korea. Chest 129: 341-348. doi:10.1378/chest.129.2.341. PubMed: 16478850. (Pubitemid 43289853)
6. van Ingen J, Bendien SA, de Lange WC, Hoefsloot W, Dekhuijzen PN et al. (2009) Clinical relevance of non-tuberculous mycobacteria isolated in the Nijmegen-Arnhem region, The Netherlands. Thorax 64: 502-506. doi:10.1136/thx.2008.110957. PubMed: 19213773.
7. Shu CC, Lee LN, Wu MF, Lee CH, Wang JT et al. (2011) Use of soluble triggering receptor expressed on myeloid cells-1 in nontuberculous mycobacterial lung disease. Int J Tuberc Lung Dis 15: 1415-1420. doi:10.5588/ijtld.10.0786. PubMed: 22283904.
8. Shu CC, Lee CH, Wang JY, Jerng JS, Yu CJ et al. (2008) Nontuberculous mycobacteria pulmonary infection in medical intensive care unit: the incidence, patient characteristics, and clinical significance. Intensive Care Med 34: 2194-2201. doi:10.1007/s00134-008-1221-6. PubMed: 18648768.
9. Kitada S, Maekura R, Toyoshima N, Fujiwara N, Yano I et al. (2002) Serodiagnosis of pulmonary disease due to Mycobacterium avium complex with an enzyme immunoassay that uses a mixture of glycopeptidolipid antigens. Clin Infect Dis 35: 1328-1335. doi:10.1086/344277. PubMed: 12439795. (Pubitemid 35448960)
10. Kitada S, Kobayashi K, Ichiyama S, Takakura S, Sakatani M et al. (2008) Serodiagnosis of Mycobacterium avium-complex pulmonary disease using an enzyme immunoassay kit. Am J Respir Crit Care Med 177: 793-797. doi:10.1164/rccm. 200705-771OC. PubMed: 18079497. (Pubitemid 351490567)
11. Kitada S, Levin A, Hiserote M, Harbeck RJ, Czaja CA et al. (2013) Serodiagnosis of Mycobacterium avium complex pulmonary disease in the United States. Eur Respir J 42: 454-460. doi:10.1183/09031936.00098212. PubMed: 23100506.
12. Wang JY, Shu CC, Lee CH, Yu CJ, Lee LN et al. (2012) Interferongamma release assay and Rifampicin therapy for household contacts of tuberculosis. J Infect 64: 291-298. doi:10.1016/j.jinf.2011.11.028. PubMed: 22207002.
13. Wang JY, Hsueh PR, Jan IS, Lee LN, Liaw YS et al. (2006) Empirical treatment with a fluoroquinolone delays the treatment for tuberculosis and is associated with a poor prognosis in endemic areas. Thorax 61: 903-908. doi:10.1136/thx.2005.056887. PubMed: 16809417.
14. Lin JW, Chang YC, Li HY, Chien YF, Wu MY et al. (2009) Cross-sectional validation of diabetes risk scores for predicting diabetes, metabolic syndrome, and chronic kidney disease in Taiwanese. Diabetes Care 32: 2294-2296. doi:10.2337/dc09-0694. PubMed: 19755627.
15. Ripoll F, Deshayes C, Pasek S, Laval F, Beretti JL et al. (2007) Genomics of glycopeptidolipid biosynthesis in Mycobacterium abscessus and M. chelonae. BMC Genomics 8: 114. doi:10.1186/1471-2164-8-114. PubMed: 17490474.
16. Schorey JS, Sweet L (2008) The mycobacterial glycopeptidolipids: structure, function, and their role in pathogenesis. Glycobiology 18: 832-841. doi:10.1093/glycob/cwn076. PubMed: 18723691.
17. Chatterjee D, Khoo KH (2001) The surface glycopeptidolipids of mycobacteria: structures and biological properties. Cell Mol Life Sci 58: 2018-2042. doi:10.1007/PL00000834. PubMed: 11814054. (Pubitemid 34019216)
18. Khan K, Wang J, Marras TK (2007) Nontuberculous mycobacterial sensitization in the United States: national trends over three decades. Am J Respir Crit Care Med 176: 306-313. doi:10.1164/rccm.200702-201OC. PubMed: 17507546. (Pubitemid 47195882)
19. Tanaka E, Kimoto T, Tsuyuguchi K, Watanabe I, Matsumoto H et al. (1999) Effect of clarithromycin regimen for Mycobacterium avium complex pulmonary disease. Am J Respir Crit Care Med 160: 866-872. doi:10.1164/ajrccm.160.3. 9811086. PubMed: 10471610. (Pubitemid 29442022)